Identity
- Security key
- 13789
- Ticker
- CRMD
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2010-05-13
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CRMD
Detail
Enriched 2026-08-14 20:47
- Market cap
- $557,008,426.1
- Shares outstanding (class)
- 78,451,891
- Shares outstanding (weighted)
- 78,451,891
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 191
- Location
- PARSIPPANY, NJ
- Homepage
- https://www.cormedix.com
- Description
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.